MARKET ANALYSIS/MARKETING STRATEGY
The (company name) will create a successful marketing plan to publish the product that we are work on ti which is lutein, in this section we will cover the following topics: the benefits of lutein to the patients who are in the early stage of AMD disease, general overview about lutein industry background, and marketing strategy and analysis.
The benefits of lutein: Our company know clearly the benefits of lutein to the patents which help to build the human density of macule pigment that also very helpful for human macule and it protect the eyes against intense light. Lutein as well classified as antioxidant that protect the cells in the human body from damaging. As well lutein keep the eyes healthy. We believe that …show more content…
• In 2010 12% of people over 50 yrs (856,000) had early signs of Macular
Degeneration
• In 2010 2% of people over 50 (167,000) had late stage Macular Degeneration which included 57,000 with Dry Macular Degeneration and 110,000 people with Wet Macular Degeneration
• Over 14% of people over 80 (123,000have vision loss or blindness from
Age-related Macular Degeneration1,3
We aim at targeting 4% of the 856,000 of the Australian population suffering from early onset AMD which comes out to be approximately 34,240 patients for the starting years. According to ARED study, maximum lutein dose is per day for a person is 50mg. Our product is in sustainable drug release capsule dosage form very helpful for aged patient.
Approximately 1.7 kg lutein is needed to achieve the initial
The (company name) will create a successful marketing plan to publish the product that we are work on ti which is lutein, in this section we will cover the following topics: the benefits of lutein to the patients who are in the early stage of AMD disease, general overview about lutein industry background, and marketing strategy and analysis.
The benefits of lutein: Our company know clearly the benefits of lutein to the patents which help to build the human density of macule pigment that also very helpful for human macule and it protect the eyes against intense light. Lutein as well classified as antioxidant that protect the cells in the human body from damaging. As well lutein keep the eyes healthy. We believe that …show more content…
• In 2010 12% of people over 50 yrs (856,000) had early signs of Macular
Degeneration
• In 2010 2% of people over 50 (167,000) had late stage Macular Degeneration which included 57,000 with Dry Macular Degeneration and 110,000 people with Wet Macular Degeneration
• Over 14% of people over 80 (123,000have vision loss or blindness from
Age-related Macular Degeneration1,3
We aim at targeting 4% of the 856,000 of the Australian population suffering from early onset AMD which comes out to be approximately 34,240 patients for the starting years. According to ARED study, maximum lutein dose is per day for a person is 50mg. Our product is in sustainable drug release capsule dosage form very helpful for aged patient.
Approximately 1.7 kg lutein is needed to achieve the initial